Entrepreneur Briefs

This computer dating service doesn't care about the color of your eyes, your favorite opera, or your search for a meaningful relationship. Money is its prime concern. Since 1984, not-for-profit Venture Capital Network has maintained a database that matches entrepreneurs seeking cash with investors hunting opportunity. For $100, entrepreneurs can include their business profiles in the VCN database for six months. Although the service can't guarantee an introduction to an investor, "almost everybo

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
This computer dating service doesn't care about the color of your eyes, your favorite opera, or your search for a meaningful relationship. Money is its prime concern. Since 1984, not-for-profit Venture Capital Network has maintained a database that matches entrepreneurs seeking cash with investors hunting opportunity. For $100, entrepreneurs can include their business profiles in the VCN database for six months. Although the service can't guarantee an introduction to an investor, "almost everybody gets matched," says project director Helen Goodman, who notes that $5 million has changed hands as a result of the network. One satisfied customer is mechanical engineer Gary Malone of Malone Applied Technology, Rochester, N.H., whose firm's work in composite materials for the airline industry attracted $100,000 in backing. For more information on VCN, and a list of its 16 affiliates across the country, contact: Venture Capital Network Inc., P.O. Box 882, Durham, N.H. 03824, (603) 862-3556.

Entrepreneur Discovers Symbiosis

The biotech firm Applied Microbiology benefits from the research of over 100 scientists but pays only one-tenth of them. How does it manage this feat? Through its alliance with the Public Health Research Institute, an independent, not-for-profit lab in Manhattan. Applied Microbiology, founded in 1983 by businessman David Guttmann, has a 20-year, exclusive license agreement on any commercially viable research that comes out of the PHRI. Most recently, this has lead to the development of a bacteriocin that kills salmonella and has potential applications in many aspects of the food industry. Applied Microbiology's symbiotic relationship with the PHRI permits the.concern's eight scientists to work in the same building as the PHRI's 22 labs; in return, the PHRI receives some research funding from Applied as well as a small chunk of equity in the firm. (PHRI researchers, however, are forbidden from holding stock in Applied.)

In The Belly Of The Beast

Mauricio Pineda, professor of veterinary medicine at Iowa State University, has hit upon a novel way to ship cattle and swine embryos cross country: recruit the warm abdomens of mice. Pineda has developed a hydrogel chamber, about the size of a grain of wheat, that can be filled with embryos and then implanted in the peritoneal cavity of a mouse. The "pregnant" mouse then carries the embryos to their final destination where they are placed in a cow or sow to develop normally. During the trip, the embryos continue to grow, sustained by growth factors from their rodent host. This method is cheaper and more successful than the current strategy of cooling embryos to ultra-low temperatures before travel and then warming them upon arrival. The device is available for licensing. For information, contact: Steven C. Price, Biotechnology Industrial Liaison, Office of Biotechnology, 1010 Agronomy, Iowa State University, Ames, Iowa 50011.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies